Epigral Limited share price

Key numbers

Market cap

₹ 4,576 Cr

Current price

₹ 1,060.60

52-week high / low

₹ 1,771 / 807

Stock P/E

17.3

Book value

₹ 514.9

Dividend yield

0.47%

ROCE

14.6%

ROE

16.1%

Debt to equity

0.26

Sales growth (3 yrs)

4.8%

Profit growth (3 yrs)

-2.1%

1-year return

-38.9%

About Epigral Limited

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-07-30)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• So what I can tell you is that going forward, we would always target to have an ROCE around 2 0%.
• Rather than giving guidance on margin, I can tell you that ROCE, we are targeting in the range of 20%.

Growth & demand

• Even against this volatile backdrop Epigral demonstrated a resilience, delivering a revenue growth of 15% and EBITDA margin of 25%.
• Epoxy Resin & Formulations is a critical material used for high performance and quality- driven applications as India grows, the demand for high quality infrastructure development, automobile, renewable energy, electronics is increasing rapidly and leading to the growth in the demand for epoxy resin.

Margins & costs

• More than 50% of the raw material value for the proposed project will be sourced internally, further strengthening our integration advantages and operational efficiency.
• EBITDA in absolute terms increased by 10% to INR179 crores compared to INR163 crores in Q1 '26.

Capex & expansion

• But we are setting up the pilot plant just to make it efficient once we commission both the plant epoxy as well as our existing mul tipurpose plant as a value -added product of ECH epichlorohydrin as well as chlorotoluenes.
• Definitely, once the plant is commissioned and that plant is also going to commission in a gradual way.

Balance sheet & cash

• Our net debt stood at INR474 crores versus INR439 crores as on 30 June '25.
• So around 60% -- 40% will be from the internal around 60% would be from the debt.

Peers in Chemicals

• Navin Fluorine International Limited
• Deepak Nitrite Limited
• Deepak Fertilisers And Petrochemicals Corporation Limited
• Tata Chemicals Limited
• Gujarat Narmada Valley Fertilizers & Chemicals Limited
• Raghav Productivity Enhancers Limited
• Archean Chemical Industries Limited
• Ellenbarrie Industrial Gases Limited
• Foseco India Limited
• Gujarat Alkalies and Chemicals Limited